missing translation for 'onlineSavingsMsg'
Learn More
Learn More
(2S)-2-[[4-[[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]benzoyl]amino]pentanedioic Acid (N-Methylfolic Acid, Methopterin), Mikromol™
Description
(2S)-2-[[4-[[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]methylamino]benzoyl]amino]pentanedioic Acid (N-Methylfolic Acid, Methopterin)
Specifications
Specifications
| Chemical Name or Material | Methopteridine |
| CAS | 2410-93-7 |
| Analyte or Component Names | Methopteridine |
| Shipping Condition | Room Temperature |
| Molecular Formula | C20 H21 N7 O6 |
| Certifications/Compliance | ISO 17025 |
| Synonym | Methotrexate Imp. C (EP), Methotrexate USP Related Compound C, Methotrexate USP RC C, N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic Acid, Glutamic acid, N-[p-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]methylamino]benzoyl]-, L- (7CI,8CI), Glutamic acid, N-[p-[[(2-amino-4-hydroxy-6-pteridinyl)methyl]methylamino]benzoyl]- (6CI), L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl]methylamino]benzoyl]- (9CI), 10-Methylfolic acid, 10-Methylpteroylglutamic acid, Methopterin, Methopterine, N10-Methylfolic acid, N10-Methylpteroylglutamic acid, NSC 107144, Methotrexate Related Compound C, Methotrexate Impurity C |
| InChI Formula | InChI=1S/C20H21N7O6/c1-27(9-11-8-22-16-15(23-11)18(31)26-20(21)25-16)12-4-2-10(3-5-12)17(30)24-13(19(32)33)6-7-14(28)29/h2-5,8,13H,6-7,9H2,1H3,(H,24,30)(H,28,29)(H,32,33)(H3,21,22,25,26,31)/t13-/m0/s1 |
| SMILES | CN(Cc1cnc2NC(=NC(=O)c2n1)N)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O |
| IUPAC Name | (2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?